OABIW vs NYT: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

NYT has stronger fundamentals based on our AI analysis.

OABIW
OmniAb, Inc.
STRONG SELL
85%
Confidence
VS
NYT
NEW YORK TIMES CO
BUY
72%
Confidence

OABIW vs NYT Fundamental Comparison

Metric OABIW NYT
Revenue $18.7M $2.8B
Net Income $-64.8M $344.0M
Net Margin -347.0% 12.2%
ROE -24.3% 16.9%
ROA -21.5% 11.5%
Current Ratio 4.02x 1.54x
Debt/Equity 0.00x 0.12x
EPS $-0.57 $2.09

Green = Better metric | Red = Weaker metric

View Full OABIW Analysis →
View Full NYT Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

OABIW vs AAPL NYT vs MSFT OABIW vs GOOGL NYT vs AMZN

OABIW vs NYT: Frequently Asked Questions

Is OABIW or NYT a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), NYT has stronger fundamentals. OABIW is rated STRONG SELL (85% confidence) while NYT is rated BUY (72% confidence). This is not investment advice.

How does OABIW compare to NYT fundamentally?

OmniAb, Inc. has ROE of -24.3% vs NEW YORK TIMES CO's 16.9%. Net margins are -347.0% vs 12.2% respectively.

Which stock pays higher dividends, OABIW or NYT?

OABIW has a dividend yield of N/A or no dividend while NYT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in OABIW or NYT for long term?

For long-term investing, consider that OABIW has STRONG SELL rating with 85% confidence, while NYT has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about OABIW vs NYT?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For OABIW vs NYT, the AI consensus favors NYT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.